Identification of cell surface molecules characterizing human cutaneous T-cell lymphomas

Area of Science:

• Immunology
• Dermatology
• Oncology

Background:

• Primary cutaneous T-cell lymphomas (CTCL) are diverse T-cell malignancies, commonly presenting as mycosis fungoides (MF) or Sezary syndrome (SS).
• Current diagnostic methods lack specific cell surface markers to differentiate malignant T-cells from normal lymphocytes in CTCL patients.

Purpose of the Study:

• To identify novel cell surface antigens with aberrant expression on CTCL cells.
• To investigate the potential of these antigens as diagnostic markers for Sezary syndrome (SS) and their role in CTCL pathophysiology.

Main Methods:

• Utilized established CTCL cell lines (Cou-LS, Pno) and freshly isolated peripheral blood lymphocytes (PBL) from SS patients.
• Detected and analyzed the expression of NK-receptor (NKR) p140/KIR3DL2 and SC5 on CTCL cells using flow cytometry and in situ staining.
• Investigated the functional role of SC5 by cross-linking its molecules and assessing its effect on malignant cell proliferation.

Main Results:

• NK-receptor (NKR) p140/KIR3DL2 was found on CTCL cell lines and SS patient CD4+ PBL, distinguishing SS cells from patch-plaque MF.
• SC5 expression was significantly increased in SS cells and correlated with p140 expression.
• Cross-linking SC5 inhibited anti-CD3 mAb-induced malignant cell proliferation.

Conclusions:

• The identified cell surface antigens, p140/KIR3DL2 and SC5, are promising markers for distinguishing SS tumor cells.
• These findings contribute to understanding CTCL pathophysiology and may offer new avenues for clinical management of SS patients.